跳至主要内容
临床试验/NCT01718821
NCT01718821已完成不适用

Assessments on Current Pain Managements in Upper Gastrointestinal Cancer Patients

National Cheng Kung University1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2012年9月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
50
试验地点
1
主要终点
Pain, assessed by BPI-SF.

研究概览

简要总结

Pain is one of the most common symptoms associated with cancer. The approach to pain management compresses routine pain assessments, utilizes both pharmacologic and nonpharmacologic interventions, and requires ongoing reevaluation of the patient. Cancer pain can be well controlled in the vast majority of patients if the algorithms of pain control are systematically applied, carefully monitored, and tailored to the needs of the individual patient.This study is aimed to assess the current pain managements in upper gastrointestinal cancer patients in Taiwan. The effects of neuropathic pain and depression on the enrolled patients would also be assessed.

研究设计

研究类型
Observational
观察模型
Ecologic Or Community
时间视角
Prospective

入排标准

年龄范围
20 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • with a diagnose of advanced upper GI cancer based on pathology or imaging studies
  • could report pain intensities and answer questionnaires by him/herself

排除标准

  • with major neurologic or psychiatric diseases
  • could not report pain intensities and answer questionnaires by him/herself

结局指标

主要结局

Pain, assessed by BPI-SF.

时间窗: Assessed at enrolled date (Day 1)

Pain intensities of participants would be assessed by BPI-SF at D1.

Changes in pain, assessed by BPI-SF.

时间窗: Baseline and 1 month.

Changes in pain intensities of participants would be assessed by BPI-SF. The changes in pain would be assessed again after 1 month when participants have outpatient visits or during their admission. An expected following duration average of would be 4 weeks.

次要结局

  • Depression, assessed by two stem questions.(Assessed at enrolled date (Day 1))
  • Changes in depression, assessed by two stem questions.(Baseline and 1 month.)
  • Quality of life, assessed by EROTC QLQ C30.(Day 1)
  • Neuropathic pain, assessed by DN4 questions.(Day 1)
  • Changes in quality of life. Quality of life, assessed by EROTC QLQ C30.(Baseline and 1 month.)
  • Changes in neuropathic pain. Neuropathic pain, assessed by DN4 questions.(Baseline and 1 month.)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Hsu-chih Chien

Doctoral student

National Cheng Kung University

研究点 (1)

Loading locations...

相似试验